BeOne Medicines
The Principal Scientist, Early Discovery & Immune Cell Engineering role at BeOne Institute leads early discovery programs within an agile biotech ecosystem, focusing on novel cell therapies for oncology and immunology indications. The position requires a blend of laboratory execution, matrix leadership, and a drug-development mindset to evaluate and advance high-potential therapeutic opportunities. The role involves driving early discovery strategy, building high-throughput screening platforms, and leading cross-functional teams to generate decision-enabling data packages.
Explore how BeOne Medicines advances global cancer care through an integrated model of discovery, development, and delivery, bringing transformative therapies to patients worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BeOne Medicines.
Scientist, Early Discovery & Immunology
BeOne Medicines
Scientist I/II, In Vitro Pharmacology
Alloy Therapeutics
Senior Scientist, Target ID, Immunology Cell Therapy Discovery
AstraZeneca
Director - Discovery Immunology
Eli Lilly and Company
Scientist, Bioscience – Cell & Mechanistic Biology
AstraZeneca
Postdoctoral Research Fellow
Mayo Clinic